Cargando…
Growth hormone and gastrointestinal malignancy: An intriguing link
Growth hormone (GH) excess is associated with several systemic complications, one of which is the increased risk of neoplastic processes particularly of the gastrointestinal (GI) tract. Among the GI neoplasms, the most reported association is with benign and malignant neoplasms of the colon. In the...
Autores principales: | Palui, Rajan, Sridharan, Kalyani, Kamalanathan, Sadishkumar, Sahoo, Jayaprakash, Naik, Dukhabandhu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896462/ https://www.ncbi.nlm.nih.gov/pubmed/36743656 http://dx.doi.org/10.4291/wjgp.v14.i1.1 |
Ejemplares similares
-
Dipeptidyl peptidase 4 inhibitors in COVID-19: Beyond glycemic control
por: Narayanan, Niya, et al.
Publicado: (2022) -
Treatment on Nature’s lap: Use of herbal products in the management of hyperglycemia
por: Giri, Somdatta, et al.
Publicado: (2023) -
Timing of osteoporosis therapies following fracture: the current
status
por: Palui, Rajan, et al.
Publicado: (2022) -
Incretin based therapy and pancreatic cancer: Realising the reality
por: Suryadevara, Varun, et al.
Publicado: (2022) -
Role of bisphosphonates in the management of acute Charcot foot
por: Durgia, Harsh, et al.
Publicado: (2018)